PubMed Health⌕ Search

Biomedical subjects

E R Lombertie

Publications and source records attributed to E R Lombertie.

8 recordsLinked to original sources
PubMed1995

[Arguments for early treatment of refractory schizophrenia].

The authors, taking up their experience and the literature, attempt to view the precociousness of alternative, classical neuroleptic treatments in schizophrenia, from notion of treatment-resistant schizophrenia, precocious refractory and intolerance. Until now, clozapine was administrated to patients lasting resistant and in mainly cases hospitalized since many years. As such as quality of life and economy of health, it would be desirable to quickly think of alternatives neuroleptic's therapeutic protocols and clozapine in the treatment-resistant schizophrenias or those presenting an intolerance.

Adult↗
PubMed1995

[Use and value of the therapeutic neuroleptic-bromocriptine combination in schizophrenia].

Use and interest of therapeutic association bromocriptine-neuroleptic in schizophrenia. Twelve schizophrenic patients were treated by bromocriptine (7.5 mg.day) and neuroleptic. After one month, patients on this treatment showed a mean improvement of 29% on the total score of the positive and negative symptom scale. This results suggest that therapeutic association bromocriptine-neuroleptic may be used for schizophrenic patients.

Adult↗
PubMed1984

[Double-blind comparative study of lorazepam and tiapride effects on the memory capacities of subjects over 60 years of age].

The authors' purpose was to confirm their hypotheses based on their prior study of the effect of tiapride and lorazepam on memorizing capacities of patients over sixty years of age. The results of a two weeks, double-blind trial show that tiapride, in addition to its sedative action, produces disinhibition and enhances wakefulness, thereby improving memory performances in the elderly.

Aging↗
PubMed1984

[Anxiolytics and mnemonic ability of the aged subject. Apropos of a double-blind study between tiapride and lorazepam].

Starting from a study of memory performances while prescription in double blind of lorazepam (2 mg/day) versus tiapride (100 mg/day), during ten days, to patients over sixty years of age, the authors try to analyse the links between anxiety, anxiolysis and attention and memory capacities. Results seem to indicate that beyond anxiolysis, these products could have an independent action over memory performances. Statistical trial of results show significantly that performances decrease under lorazepam and increase under tiapride.

Aged↗